Budget Amount *help |
¥18,460,000 (Direct Cost: ¥14,200,000、Indirect Cost: ¥4,260,000)
Fiscal Year 2011: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2010: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2009: ¥6,890,000 (Direct Cost: ¥5,300,000、Indirect Cost: ¥1,590,000)
|
Research Abstract |
CAST method was carried out on esophago-gastric cancers and identified DSC2, TSPAN8, TM9SF3, etc. as possible therapeutic target. By microRNA microarray, several microRNAs were identified as diagnostic marker. miR-148a and miR-143 were found to participate in invasion and morphogenesis. New development of diagnosis and therapeutics using novel markers is expected
|